Walgreens Board Says It Reacted Quickly To Theranos Fraud
The directors of pharmacy chain Walgreens told a Delaware Chancery judge Wednesday that they reacted swiftly to news of fraud from diagnostic testing company Theranos Inc., so an investor derivative suit...To view the full article, register now.
Already a subscriber? Click here to view full article